Cystic fibrosis mutations and genotype-pulmonary phenotype analysis

Journal of Cystic Fibrosis

Volumn 5, Issue 1, 2006, Pages 33-41

  Braun, Andrew T ^a,b,c   Farrell, Philip M ^a,b,c   Ferec, Claude ^a,b,c   Audrezet, Marie Pierre ^a,b,c   Laxova, Anita ^a,b,c   Li, Zhanhai ^a,b,c   Kosorok, Michael R ^a,b,c   Rosenberg, Marjorie A ^a,b,c   Gershan, William M ^a,b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

Author keywords

Cystic fibrosis; Genotype; Lung disease; Phenotype

Indexed keywords

AZITHROMYCIN; DEOXYRIBONUCLEASE; TOBRAMYCIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CHILD; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CYSTIC FIBROSIS; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DISEASE COURSE; DNA EXTRACTION; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HOMOZYGOSITY; HUMAN; LUNG FUNCTION TEST; LUNG INFECTION; MALE; NUCLEIC ACID BASE SUBSTITUTION; PANCREAS FUNCTION; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; THORAX RADIOGRAPHY;

CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE PROGRESSION; DNA; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; PHENOTYPE; POINT MUTATION; PROGNOSIS; PROSPECTIVE STUDIES; RADIOGRAPHY, THORACIC; SEVERITY OF ILLNESS INDEX; SPIROMETRY;

EID: 31344465227     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2005.09.008     Document Type: Article

References (38)

1. M.J. Welsh L.C. Tsui T.F. Boat A.L. Beaudet Cystic fibrosis C.R. Scriver A.L. Beaudet W.S. Sly D. Valle The metabolic and molecular bases of inherited disease 17th ed. 1995 McGraw-Hill New York 3799-3876
2. J.L. Bobadilla M. Macek Jr. J.P. Fine P.M. Farrell Cystic fibrosis: A world-wide analysis for CFTR mutations - correlation with incidence data and application to screening Hum Mutat 19 2002 575-606
3. Cystic Fibrosis Genotype-Phenotype Consortium Correlation between genotype and phenotype in patients with cystic fibrosis N Engl J Med 3 1993 1308-1313
4. J. Zielenski L.C. Tsui Cystic fibrosis genotypic and phenotypic variations Annu Rev Genet 29 1995 777-807
5. Cystic Fibrosis Genetic Analysis Consortium: http://www.genet.sickkids.on.ca/cftr.
6. P. Kubesch T. Dork U. Wulbrand N. Kalin T. Neumann B. Wulf et al. Genetic determinants of airways' colonization with Pseudomonas aeruginosa in cystic fibrosis Lancet 341 1993 189-193
7. P. Kristidis D. Bozon M. Corey D. Markiewicz J. Rommens L.C. Tsui et al. Genetic determinants of exocrine pancreatic function in cystic fibrosis Am J Hum Genet 50 1992 1178-1184
8. R.T. Mohon J.S. Wagener S.H. Abman W.K. Seltzer F.J. Accurso Relationship of genotype to early pulmonary function in infants with cystic fibrosis identified through neonatal screening J Pediatr 122 1993 550-555
9. L.A. Lester J. Kraut J. Lloyd-Still T. Karrison C. Mott C. Billstrand et al. F508del genotype does not predict disease severity in an ethnically diverse cystic fibrosis population Pediatrics 93 1994 114-118
10. I. Duguépéroux M. De Braekeleer Genotype-phenotype relationship for five CFTR mutations frequently identified in western France J Cystic Fibrosis 3 2004 259-263
11. C. Koch H. Cuppens M. Rainislo U. Madessani H.K. Harms M.E. Hodson et al. European epidemiologic registry of cystic fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations Pediatr Pulmonol 31 2001 1-12
12. A.S. Ramalho S. Beck M. Meyer D. Penque G.R. Cutting M.D. Amaral Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis Am J Respir Cell Mol Biol 27 2002 619-627
13. E.F. McKone S.S. Emerson K.L. Edwards M.L. Aitken Effect of genotype on phenotype and mortality in cystic fibrosis: A retrospective cohort study The Lancet 361 2003 1671-1676
14. D.L. Waters S.F.A. Dorney K.J. Gaskin M.A. Gruca M. O'Halloran B. Wilcken Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program N Engl J Med 322 1990 303-308
15. P.M. Farrell M.R. Kosorok A. Laxova G. Shen R.E. Koscik W.T. Bruns et al. Nutritional benefits of newborn screening for cystic fibrosis N Engl J Med 337 1997 963-969
16. P.M. Farrell and the Wisconsin Cystic Fibrosis Neonatal Screening Study Group Improving the health of patients with cystic fibrosis through newborn screening Adv Pediatr 47 2000 79-115
17. H.C. Lai M.R. Kosorok A. Laxova L.A. Davis S.C. FitzSimmon P.M. Farrell Nutritional status of patients with cystic fibrosis with meconium ileus: a comparison with patients without meconium ileus and diagnosed early through neonatal screening Pediatrics 105 2000 53-61
18. J.L. Bobadilla M.H. Farrell P.M. Farrell Applying CFTR molecular genetics to facilitate the diagnosis of cystic fibrosis through screening Adv Pediatr 49 2002 131-190
19. M.J. Welsch A.E. Smith Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis Cell 73 1993 1251-1254
20. P.M. Farrell Z. Li M.R. Kosorok A. Laxova C.G. Green J. Collins et al. Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis Pediatr Pulmonol 36 2003 230-240
21. M.R. Kosorok L. Zeng She West M.J. Rock M.L. Spalingard A. Laxova et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition Pediatr Pulmonol 32 2001 277-287
22. M.R. Kosorok M. Jalaluddin P.M. Farrell G. Shen C.E. Colby A. Laxova et al. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis Pediatr Pulmonol 26 1998 81-88
23. M. Corey L. Edwards H. Levison M. Knowles Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis J Pediatr 131 1997 809-814
24. L. Drittantl M.V. Masciovecchio J. Gabbarini M. Vega Editorial: Cystic fibrosis: Gene therapy or preventive gene transfer? Gene Ther 4 1997 1001-1003
25. C. Koch Early infection and progression of cystic fibrosis lung disease Pediatr Pulmonol 34 2002 91-100
26. P.M. Farrell Z. Li M.R. Kosorok A. Laxova C.G. Green J. Collins et al. Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis Am J Respir Crit Care Med 168 2003 1100-1108
27. C. Le Maréchal M.P. Audrézet I. Quéré O. Raguènes S. Langonne Férec Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator gene by denaturing high-performance liquid chromatography: Major implications for genetic counseling Hum Genet 108 2001 290-298
28. P.M. Farrell J.G. Bieri J.F. Fratantoni R.E. Wood P.A. di Sant'Agnese The occurrence and effects of human vitamin E deficiency: A study in patients with cystic fibrosis J Clin Invest 60 1977 233-241
29. H.C. Lai M.R. Kosorok A. Laxova L.M. Makholm P.M. Farrell Delayed diagnosis of US females with cystic fibrosis Am J Epidemiol 156 2002 165-173
30. R.E. Koscik M.R. Kosorok P.M. Farrell J. Collins M.E. Peters A. Laxova et al. Wisconsin cystic fibrosis chest radiograph scoring system: validation and standardization for application to longitudinal studies Pediatr Pulmonol 29 2000 457-467
31. D. Brasfield G. Hicks S. Song R.E. Tiller The chest roentgenogram in cystic fibrosis: A new scoring system Pediatrics 63 1979 24-29
32. S. West L. Zeng B.L. Lee M.R. Kosorok A. Laxova M.J. Rock et al. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: Early detection by serology and assessment of risk factors JAMA 287 2002 2958-2967
33. X. Wang D.W. Dockery D. Wypij M.E. Fay B.G. Ferris Pulmonary function between 6 and 18 years of age Pediatr Pulmonol 15 1993 75-88
34. J.T. den Dunnen E. Antonarakis Nomenclature for the description of human sequence variations Hum Genet 109 2001 121-124
35. J. Zielenski M. Corey R. Rozmahel D. Markiewicz I. Aznarez T. Casal et al. Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13 Nat Genet 22 1999 128-129
36. M. Corey L. Edwards H. Levison M. Knowles Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis J Pediatr 131 1997 809-814
37. Z. Li M.R. Kosorok P.M. Farrell A. Laxova S.H.E. West C.G. Green et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis JAMA 293 2005 581-588
38. S. Terheggen-Largro N. Truijens N. van Poppel V. Gulmans J. van der Laag C. van der Ent Correlation of six different cystic fibrosis chest radiograph scoring systems with clinical parameters Pediatr Pulmonol 35 2003 441-445